Physician

Ekama Carlson, MD, PHD

According to 2025 Medicare claims, Ekama Carlson, MD, PHD (NPI: 1245532159) practices micrographic dermatologic surgery in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Francisco, CA. This provider's primary affiliated billing organization is CARLSON SURGICAL DERMATOLOGY CORP (NPI: 1912649096; TIN: 881283895) and primary practice location at 94115-2381.

Carlson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 153 traditional Medicare patients, billed 793 HCPCS/CPT codes, and received $155,283 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 166 prescription claims across 100 beneficiaries totaling $4,239 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 27 records totaling $756. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $8,100 to $4,239. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$78K$155K2022 Medicare payment: $31,254 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $148,172 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $155,283 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202244124$31,254
2023125738$148,172
2024153793$155,283

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$33K2017 Drug cost: $8,100 (USD; Tot_Drug_Cst)2018 Drug cost: $32,566 (USD; Tot_Drug_Cst)2019 Drug cost: $5,679 (USD; Tot_Drug_Cst)2020 Drug cost: $4,790 (USD; Tot_Drug_Cst)2021 Drug cost: $1,569 (USD; Tot_Drug_Cst)2022 Drug cost: $1,254 (USD; Tot_Drug_Cst)2023 Drug cost: $3,208 (USD; Tot_Drug_Cst)2024 Drug cost: $4,239 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201792116$8,100
2018211381$32,566
2019160202$5,679
2020189241$4,790
20218398$1,569
20227080$1,254
202364103$3,208
2024100166$4,239

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks4253$492
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more3939$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4361$81
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more62112$53
17000Destruction of precancer skin growth, 1 growth3037$49

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate22550$615
CefadroxilCefadroxil51464$411
Doxycycline HyclateDoxycycline Hyclate14182$218
Triamcinolone AcetonideTriamcinolone Acetonide14364$141

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.27$756ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ekama Carlson, MD, PHD?

Tedicare shows public-source Medicare data for Ekama Carlson, MD, PHD (NPI 1245532159), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ekama Carlson, MD, PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ekama Carlson, MD, PHD?

Ekama Carlson, MD, PHD is linked to CARLSON SURGICAL DERMATOLOGY CORP (billing NPI 1912649096) in the available physician profile data.

Does Ekama Carlson, MD, PHD have Open Payments data?

Ekama Carlson, MD, PHD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.